Xenobiotic-induced peroxisome proliferation: role of tissue specificity and species differences in response in the evaluation of the implications for human health
- PMID: 3555419
- DOI: 10.1007/978-3-642-71617-1_4
Xenobiotic-induced peroxisome proliferation: role of tissue specificity and species differences in response in the evaluation of the implications for human health
Abstract
Significant increases in the number of peroxisomes and in the activity of H2O2 generating peroxisomal fatty acid beta-oxidation enzyme system occur in liver parenchymal cells of mice, rats and certain other species exposed to several structurally dissimilar hypolipidemic drugs and certain phthalate-ester plasticizers. These agents, referred to as peroxisome proliferators, are considered as novel hepatocarcinogenic agents in view of their non-mutagenic and non-genotoxic nature. The lack of mutagenicity of these agents combined with consistent coupling of proliferation of H2O2 generating peroxisomes led to the hypothesis that persistent proliferation of peroxisomes serves as an endogenous initiator of neoplastic transformation by inducing oxidative stress. The mechanism by which oxidative stress leads to neoplastic transformation is, however, not clear. This postulated link between peroxisome proliferation and carcinogenicity implies that tumors should develop only in organs displaying profound peroxisome proliferation. Current evidence indicates that maximal peroxisome proliferation is a tissue-specific phenomenon, restricted largely to the hepatocyte. This tissue-specific biological response suggests that interaction of these structurally dissimilar xenobiotics with a receptor(s) might be the mechanism responsible for peroxisome proliferation and the selective increase in the rate of transcription of peroxisomal fatty acid beta-oxidation enzyme genes without significantly affecting the transcriptional rate of peroxisomal marker enzyme catalase gene. Identification and molecular characterization of peroxisome proliferator specific receptor(s) and elucidation of the mechanisms responsible for the differences in interspecies responses will be necessary for the evaluation of the implications for human health, since the carcinogenicity is not directly attributable to the chemical but to the adaptive responses of the host.
Similar articles
-
Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.Toxicol Appl Pharmacol. 1989 Jan;97(1):72-87. doi: 10.1016/0041-008x(89)90056-2. Toxicol Appl Pharmacol. 1989. PMID: 2916237
-
Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.Environ Health Perspect. 1986 Mar;65:317-27. doi: 10.1289/ehp.8665317. Environ Health Perspect. 1986. PMID: 3709457 Free PMC article.
-
Long-term effects of peroxisome proliferators on the balance between hydrogen peroxide-generating and scavenging capacities in the liver of Fischer-344 rats.Toxicology. 1990 Aug;63(2):199-213. doi: 10.1016/0300-483x(90)90043-g. Toxicology. 1990. PMID: 2399535
-
Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?Environ Health Perspect. 2001 May;109(5):437-42. doi: 10.1289/ehp.01109437. Environ Health Perspect. 2001. PMID: 11401753 Free PMC article. Review.
-
A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.Regul Toxicol Pharmacol. 1999 Jun;29(3):327-57. doi: 10.1006/rtph.1999.1296. Regul Toxicol Pharmacol. 1999. PMID: 10388618 Review.
Cited by
-
Redox interplay between mitochondria and peroxisomes.Front Cell Dev Biol. 2015 May 27;3:35. doi: 10.3389/fcell.2015.00035. eCollection 2015. Front Cell Dev Biol. 2015. PMID: 26075204 Free PMC article. Review.
-
Incorporating Tissue-Specific Gene Expression Data to Improve Chemical-Disease Inference of in Silico Toxicogenomics Methods.J Xenobiot. 2024 Jul 31;14(3):1023-1035. doi: 10.3390/jox14030057. J Xenobiot. 2024. PMID: 39189172 Free PMC article.
-
Alzheimer's Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α.Cells. 2020 May 14;9(5):1215. doi: 10.3390/cells9051215. Cells. 2020. PMID: 32422896 Free PMC article. Review.